Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Obesity (Silver Spring, Md.)
|
January 11, 2018
Neurotensin and Nonalcoholic Fatty Liver Disease: Beyond Obesity
Juan Pedro-Botet, David Benaiges
Medicina Clinica
|
February 5, 2022
Bariatric surgery and non-alcoholic fatty liver disease
Helena Julià, David Benaiges, Juan Pedro-Botet
Obesity Surgery
|
November 28, 2024
Time to Put LDL Cholesterol on the Roadmap in Bariatric Surgery Guidelines
David Benaiges, Juan Pedro-Botet, Anna Casajoana
Frontiers in Cardiovascular Medicine
|
June 7, 2021
Hydrophilic or Lipophilic Statins?
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Medicina Clinica
|
June 24, 2020
Atherosclerosis and inflammation. New therapeutic approaches
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Biomedicines
|
August 6, 2021
Familial Hypercholesterolemia: Do HDL Play a Role?
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Expert Opinion on Drug Safety
|
May 10, 2019
Muscle and statins: from toxicity to the nocebo effect
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
February 10, 2019
Statin treatment and increased diabetes risk. Possible mechanisms
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
February 10, 2020
Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular disease
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
July 23, 2024
LDL cholesterol as a causal agent of atherosclerosis
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Obesity (Silver Spring, Md.)
|
January 11, 2018
Neurotensin and Nonalcoholic Fatty Liver Disease: Beyond Obesity
Juan Pedro-Botet, David Benaiges
Medicina Clinica
|
February 5, 2022
Bariatric surgery and non-alcoholic fatty liver disease
Helena Julià, David Benaiges, Juan Pedro-Botet
Obesity Surgery
|
November 28, 2024
Time to Put LDL Cholesterol on the Roadmap in Bariatric Surgery Guidelines
David Benaiges, Juan Pedro-Botet, Anna Casajoana
Frontiers in Cardiovascular Medicine
|
June 7, 2021
Hydrophilic or Lipophilic Statins?
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Medicina Clinica
|
June 24, 2020
Atherosclerosis and inflammation. New therapeutic approaches
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Biomedicines
|
August 6, 2021
Familial Hypercholesterolemia: Do HDL Play a Role?
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Expert Opinion on Drug Safety
|
May 10, 2019
Muscle and statins: from toxicity to the nocebo effect
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
February 10, 2019
Statin treatment and increased diabetes risk. Possible mechanisms
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
February 10, 2020
Lipid-lowering treatment in secondary prevention of ischaemic cerebrovascular disease
Elisenda Climent, David Benaiges, Juan Pedro-Botet
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
July 23, 2024
LDL cholesterol as a causal agent of atherosclerosis
Juan Pedro-Botet, Elisenda Climent, David Benaiges
Page
of 11